BioMS Medical Corp.

Headquarters
8812 - 60 AvenueEdmonton, Alberta
T6E 6A6 Canada
Telephone
(780) 413-7152Fax
(780) 408-3040Website
www.biomsmedical.comFor additional info., contact
Montréal
Telephone: (514) 939-3989Fax: (514) 939-3717
Toronto
Telephone: (416) 644-2020Fax: (416) 644-2021
Financial Information
Stock Symbol (TSX):
MS.T
Current Price:
0.36
Current Volume:
45,194
52 Week High / Low :
3.90 / 0.26
Shares Outstanding
:
91,008,923
Fully Diluted Shares:
127,259,451
Est. Market Float:
-
Market Cap.:
32,763,212
EPS last 3 months:
0.02
EPS Trailing 12 months:
0.00
Long-Term Debt:
-
Financial Year-End:
December 31
About BioMS Medical Corp.
BioMS Medical is a biotechnology company engaged in the investment, development and commercialization of pharmaceutical technologies.
Management
Kevin Giese
President & Chief Executive Officer
Dr. Kjell Stenberg
Chief Operating Officer
Brent Johnston
Chief Financial Officer
Tony Hesby
Executive Vice-President
Richard Brown
Vice-President, Commercial Development
Dr. Tony Verco
Vice-President, Drug Development
Randy Stroud
Vice-President, Regulatory Affairs
Ryan Giese
Vice-President, Corporate Communications
Board of Directors
Clifford Giese
Chairman
Kevin Giese
Director
Dr. Kjell Stenberg
Director
Laine Wollard
Director
Dr. John Wetherell
Director
William D. Grace
Director
Gordon Politeski
Director
Latest Press Releases
-
March 3, 2010
BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19 .5 million -
December 17, 2009
BioMS Medical provides corporate update -
December 17, 2009
Spectra diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis -
November 12, 2009
BioMS Medical Announces Third Quarter 2009 Results -
September 2, 2009
BioMS Medical Provides Update on Dirucotide
Financials
-
November 12, 2009
Third Quarter 2009 -
July 17, 2009
Second Quarter 2009 -
May 12, 2009
First Quarter 2009 -
March 27, 2009
2008 Annual Report

